Identification and Verification of m7G Modification Patterns and Characterization of Tumor Microenvironment Infiltration via Multi-Omics Analysis in Clear Cell Renal Cell Carcinoma

The epigenetic modification of tumorigenesis and progression in neoplasm has been demonstrated in recent studies. Nevertheless, the underlying association of N7-methylguanosine (m(7)G) regulation with molecular heterogeneity and tumor microenvironment (TME) in clear cell renal cell carcinoma (ccRCC) remains unknown. We explored the expression profiles and genetic variation features of m(7)G regulators and identified their correlations with patient outcomes in pan-cancer. Three distinct m(7)G modification patterns, including MGCS1, MGCS2, and MGCS3, were further determined and systematically characterized via multi-omics data in ccRCC. Compared with the other two subtypes, patients in MGCS3 exhibited a lower clinical stage/grade and better prognosis. MGCS1 showed the lowest enrichment of metabolic activities. MGCS2 was characterized by the suppression of immunity. We then established and validated a scoring tool named m7Sig, which could predict the prognosis of ccRCC patients. This study revealed that m(7)G modification played a vital role in the formation of the tumor microenvironment in ccRCC. Evaluating the m(7)G modification landscape helps us to raise awareness and strengthen the understanding of ccRCC's characterization and, furthermore, to guide future clinical decision making.

Automated summary

The study demonstrated the importance of N7-methylguanosine (m(7)G) modification in clear cell renal cell carcinoma (ccRCC). Three distinct m(7)G modification patterns were identified and characterized, and a scoring tool called m7Sig was developed to predict patient prognosis. Understanding m(7)G modification landscape can help improve the characterization and clinical decision making in ccRCC.